This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2022
Title: Donna Marie Driscoll: Innovator in IL-17a Related Treatments
Introduction
Donna Marie Driscoll is a prominent inventor based in Cleveland, OH (US). She has made significant contributions to the field of medical research, particularly in the treatment of IL-17a related diseases and conditions. Her innovative work has the potential to impact many lives.
Latest Patents
Driscoll holds a patent for "SBE aptamers for treating IL-17a related diseases and conditions." This patent includes compositions, systems, kits, and methods that utilize an SBE nucleic acid sequence to bind a SEFIR domain of an ACT1 protein. This groundbreaking approach offers new avenues for treatment in this critical area of healthcare. She has 1 patent to her name.
Career Highlights
Throughout her career, Driscoll has demonstrated a commitment to advancing medical science. Her research focuses on innovative solutions that address complex health issues. She has established herself as a key figure in her field, contributing valuable insights and developments.
Collaborations
Driscoll has worked alongside talented colleagues, including Lingzi Hong and Tomasz Herjan. These collaborations have fostered a dynamic environment for innovation and research.
Conclusion
Donna Marie Driscoll is a remarkable inventor whose work in IL-17a related treatments showcases her dedication to improving healthcare. Her contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile